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W
hy is World Kidney Day an occasion 
to raise the issue of whether or not 
the kidney is involved in the genesis 
of high blood pressure? High blood 
pressure aff ects approximately 30% of the adult 
population in Western countries,1 tendency ris-
ing, and even 80% of people older than 80 years, 
so that a cynic stated, “Th e only safeguard against 
hypertension is to die early.” Th e burden of high 
blood pressure is a major, if not the major, public 
health problem.2
Why is high blood pressure so important from a 
public-health perspective?
High blood pressure, not necessarily the ‘dis-
ease’ hypertension according to current defi ni-
tions (JNC 7),3 is a major killer, accounting for 
stroke, cardiac death, and progressive loss of kid-
ney function. If a person has a blood pressure of 
140 mm Hg systolic, as compared with 120 mm 
Hg systolic, the risk of stroke or myocardial inf-
arction is already double, and it doubles further 
for every 20 mm Hg of further increase.4 With 
a systolic blood pressure of 120–130 mm Hg, 
instead of less than 120 mm Hg, the risk of end-
stage renal disease is higher by 62%, and, with a 
pressure of 130–140 mm Hg, is higher even by 
159%. In diabetic patients the risk increment is 
much higher still.5
It had been known since the beginning of the 
nineteenth century that patients with kidney 
disease suff er from hypertension.6 Th e classical 
experiment of Guyton7 showed that stable eleva-
tion of blood pressure in the absence of kidney 
disease requires a subtle malfunction of the kid-
ney whereby sodium reabsorption is increased. 
In this setting, higher blood pressure is necessary 
to rid the organism of ingested sodium. Conclu-
sive evidence for the crucial role of the kidney in 
individuals with hypertension was demonstrated 
by Curtis:8 he observed six hypertensive patients 
who had developed dialysis-dependent kidney 
failure as a result of hypertensive kidney dam-
age in the absence of a primary kidney disease. 
Aft er transplantation of a kidney from a donor 
with normal blood pressure, these kidney graft  
recipients remained normotensive even 5 years 
aft er transplantation. Although hypertension is 
a polygenic disorder that is dependent on the 
interaction among several genetic defects, all rare 
monogenic forms of hereditary hypertension have 
one common denominator: increased sodium 
reabsorption by the kidney at diff erent sites and 
by diff erent mechanisms along the tubules.9
Recently, more insight into the link between a 
kidney abnormality and hypertension in ‘run-of-
the-mill’ essential hypertension has been provided 
by anatomical studies of the kidney. Th e number 
of glomeruli, and, by implication, of tubules, in 
the kidney of normal individuals varies between 
0.8 and 1.8 million.10 A British epidemiologist, 
DJ Barker, and his colleagues11 had proposed that 
faulty prenatal programming during the phase of 
organogenesis in utero predisposed to hyperten-
sion in adult age. B.M. Brenner and colleagues12 
carried this one step further by proposing that 
a lower number of nephrons at birth (‘nephron 
underdosing’) predisposed to hypertension and 
kidney malfunction in adult age. Th is hypothesis 
was supported by animal experiments indicat-
ing that reduced uterine perfusion or maternal 
malnutrition during a critical phase of renal 
organogenesis caused hypertension at adult age. 
More recently, when comparing the number of 
glomeruli in the kidneys of adults with and with-
out hypertension, Keller et al.13 found that hyper-
tensive individuals have roughly half the number 
of nephrons that normotensive individuals have, 
and this fi nding has since been confi rmed.14,15
Th is observation immediately raises the issue of 
whether one currently practiced procedure, live 
kidney donation, is harmful and causes hyper-
tension. Follow-up studies on kidney donors 
showed that there was no evidence of increased 
blood pressure,16 perhaps because loss of renal 
mass before or immediately aft er birth on the one 
hand and loss of renal mass at adult age on the 
other hand might have diff erent eff ects on blood 
pressure.17 Another apparent paradox is that, in 
hypertensive individuals with a reduced number 
of glomeruli, the calculated fi ltration surface is 
still in the normal range, because the glomeruli 
are hypertrophic. So it is not gross kidney mal-
function, but more subtle defects of the function 
of postglomerular segments of the nephron, that 
account for the rise in blood pressure. Other 
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relevant factors such as increased tubular reab-
sorption of sodium,18 increased vasoconstric-
tion in response to angiotensin II,19 increased 
stimulation of the mineralocorticoid receptor 
because of decreased metabolism of cortisol,20 
and increased sympathetic activity21 also need 
to be considered.
As a result, the kidney has moved to the center 
of current studies to unravel the genesis of hyper-
tension. On the other hand, apart from the heart 
and the brain, the kidney is also a major target 
of hypertension-induced damage, justifying the 
statement that the kidney is at the same time 
‘culprit’ as well as ‘victim’ of hypertension.22
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